Bannink, Marjolein <br/><br/>
Interferon-alpha in oncology patients: fewer psychiatric side effects than anticipated.  [electronic resource] 

 -  Psychosomatics   
 - 56-63 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0033-3182 
<br/><br/><label>Standard No.: </label>10.1176/appi.psy.49.1.56  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--adverse effects<br/>Anxiety Disorders--chemically induced<br/>Carcinoma, Renal Cell--drug therapy<br/>Cross-Sectional Studies<br/>Depressive Disorder, Major--chemically induced<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Injections, Subcutaneous<br/>Interferon alpha-2<br/>Interferon-alpha--adverse effects<br/>Kidney Neoplasms--drug therapy<br/>Male<br/>Melanoma--drug therapy<br/>Middle Aged<br/>Personality Inventory<br/>Polyethylene Glycols--adverse effects<br/>Recombinant Proteins<br/>Risk Factors<br/>Skin Neoplasms--drug therapy